Deloitte’s 2026 Healthcare Outlook shows that while more than two-thirds of U.S. healthcare leaders expect to outperform competitors, rising policy uncertainty is pushing greater focus on digital care ...
More than 50 major insurers have pledged to streamline prior authorization starting in 2026, but providers remain cautiously optimistic and skeptical that the changes will truly reduce burden or ...
A coalition of major pharmacy organizations urged Congressional leaders to enact long-stalled PBM reforms to curb ...
Texas Attorney General Ken Paxton sued Epic, alleging the company monopolizes the EHR market and restricts access to medical ...
Recent changes to ACIP leadership and vaccine guidance have raised concerns that longstanding immunization protections are ...
The Senate’s rejection of two ACA-focused healthcare bills widened partisan divides and sparked warnings from advocacy groups ...
Rare disease drug developer BioMarin Pharmaceutical is buying its way to revenue growth with a $4.8 billion deal for Amicus Therapeutics, a company whose two commercialized products each offer ...
Senate Finance Committee Chairman Mike Crapo (R-Idaho) and Ranking Member Ron Wyden (D-Oregon) introduced a bill Thursday that aims to bring more transparency into the practices of pharmacy benefit ...
Mark Cuban warned that many employers are collecting drug rebate money funded by their sick employees — a practice that can ...
Trust in the U.S. healthcare system is eroding — but this decline isn’t happening evenly across the system, one leader pointed out. People largely trust individual clinicians, but they tend to ...
That term has become the industry shorthand for assuring people nervous about AI’s increasing foothold in healthcare. There’s always someone watching over what AI does. We are there to make sure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback